Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Circulation 2020 Jun 15
Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor-Associated Myocarditis.
Related Questions
For patients on immune checkpoint inhibitors presenting with chest pain, dyspnea, fatigue, and troponin elevation, would you recommend early initiation of high dose steroids for empiric treatment of ICI myocarditis while pursuing workup with coronary angiogram, echocardiogram, and/or cardiac MRI, or wait until alternative etiologies have been ruled out?
New comment
by at FibroFighters Foundation ( June 29, 2023)
Do you use tocilizumab? Or only if steroids fail? I ask because tocilizumab has anti-cancer properties and can promote IL-12 - which enhances immune-mediated cancer effect, w...
Read more (2 Answers available)
16315
×
To continue please login or register
Register
or
Sign in